APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lurasidone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lurasidone Industry Growth and Trends Forecast to 2032

Report ID 174009450131 December 202590 pages

Choose your research edition.

Industry ResearchLurasidone Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Lurasidone Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Lurasidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lurasidone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Lurasidone Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lurasidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lurasidone include Zhejiang Hisun Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Square Pharmaceuticals Ltd., RemedyRepack，Inc., Incepta Pharmaceuticals Ltd., Healthcare Pharmaceuticals Limited, Bushu Pharmaceutical, LTD. and Angelini Holding S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lurasidone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lurasidone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lurasidone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lurasidone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lurasidone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lurasidone Market by Company

Zhejiang Hisun Pharmaceutical Co., Ltd.

Sumitomo Dainippon Pharma Co., Ltd.

Square Pharmaceuticals Ltd.

RemedyRepack，Inc.

Incepta Pharmaceuticals Ltd.

Healthcare Pharmaceuticals Limited

Bushu Pharmaceutical, LTD.

Angelini Holding S.p.A.

Lurasidone Segment by Type

120mg/tablet

20mg/tablet

40mg/tablet

60mg/tablet

80mg/tablet

Lurasidone Segment by Application

Hospital

Psychological Clinic

Others

Lurasidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lurasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lurasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 120mg/tablet Table 2. Major Company of 20mg/tablet Table 3. Major Company of 40mg/tablet Table 4. Major Company of 60mg/tablet Table 5. Major Company of 80mg/tablet Table 6. Global Lurasidone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Lurasidone Sales by Type (2021-2026) & (K Units) Table 8. Global Lurasidone Sales Market Share in Volume by Type (2021-2026) Table 9. Global Lurasidone Sales by Type (2021-2026) & (US$ Million) Table 10. Global Lurasidone Sales Market Share in Value by Type (2021-2026) Table 11. Global Lurasidone Price by Type (2021-2026) & (US$/Unit) Table 12. Global Lurasidone Sales by Type (2027-2032) & (K Units) Table 13. Global Lurasidone Sales Market Share in Volume by Type (2027-2032) Table 14. Global Lurasidone Sales by Type (2027-2032) & (US$ Million) Table 15. Global Lurasidone Sales Market Share in Value by Type (2027-2032) Table 16. Global Lurasidone Price by Type (2027-2032) & (US$/Unit) Table 17. North America Lurasidone Sales by Type (2021-2026) & (K Units) Table 18. North America Lurasidone Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Lurasidone Sales by Type (2021-2026) & (K Units) Table 20. Europe Lurasidone Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Lurasidone Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Lurasidone Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Lurasidone Sales by Type (2021-2026) & (K Units) Table 24. Latin America Lurasidone Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Lurasidone Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Lurasidone Sales by Type (2021-2026) & (US$ Million) Table 27. Lurasidone Industry Trends Table 28. Lurasidone Industry Drivers Table 29. Lurasidone Industry Opportunities and Challenges Table 30. Lurasidone Industry Restraints Table 31. Global Lurasidone Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Lurasidone Revenue Market Share by Company (2021-2026) Table 33. Global Lurasidone Sales by Company (2021-2026) & (K Units) Table 34. Global Lurasidone Sales Share by Company (2021-2026) Table 35. Global Lurasidone Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Lurasidone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Lurasidone Major Company Production Sites and Headquarters Table 38. Global Lurasidone Company, Product Type & Application Table 39. Global Lurasidone Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Lurasidone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Lurasidone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Lurasidone Sales by Region (2021-2026) & (K Units) Table 44. Global Lurasidone Sales Market Share in Volume by Region (2021-2026) Table 45. Global Lurasidone Sales by Region (2021-2026) & (US$ Million) Table 46. Global Lurasidone Sales Market Share in Value by Region (2021-2026) Table 47. Global Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Lurasidone Sales by Region (2027-2032) & (K Units) Table 49. Global Lurasidone Sales Market Share in Volume by Region (2027-2032) Table 50. Global Lurasidone Sales by Region (2027-2032) & (US$ Million) Table 51. Global Lurasidone Sales Market Share in Value by Region (2027-2032) Table 52. Global Lurasidone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Lurasidone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Lurasidone Sales by Application (2021-2026) & (K Units) Table 55. Global Lurasidone Sales Market Share in Volume by Application (2021-2026) Table 56. Global Lurasidone Sales by Application (2021-2026) & (US$ Million) Table 57. Global Lurasidone Sales Market Share in Value by Application (2021-2026) Table 58. Global Lurasidone Price by Application (2021-2026) & (US$/Unit) Table 59. Global Lurasidone Sales by Application (2027-2032) & (K Units) Table 60. Global Lurasidone Sales Market Share in Volume by Application (2027-2032) Table 61. Global Lurasidone Sales by Application (2027-2032) & (US$ Million) Table 62. Global Lurasidone Sales Market Share in Value by Application (2027-2032) Table 63. Global Lurasidone Price by Application (2027-2032) & (US$/Unit) Table 64. North America Lurasidone Sales by Application (2021-2026) & (K Units) Table 65. North America Lurasidone Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Lurasidone Sales by Application (2021-2026) & (K Units) Table 67. Europe Lurasidone Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Lurasidone Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Lurasidone Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Lurasidone Sales by Application (2021-2026) & (K Units) Table 71. Latin America Lurasidone Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Lurasidone Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Lurasidone Sales by Application (2021-2026) & (US$ Million) Table 74. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 75. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 76. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio Table 78. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 79. Sumitomo Dainippon Pharma Co., Ltd. Company Information Table 80. Sumitomo Dainippon Pharma Co., Ltd. Business Overview Table 81. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio Table 83. Sumitomo Dainippon Pharma Co., Ltd. Recent Development Table 84. Square Pharmaceuticals Ltd. Company Information Table 85. Square Pharmaceuticals Ltd. Business Overview Table 86. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Square Pharmaceuticals Ltd. Lurasidone Product Portfolio Table 88. Square Pharmaceuticals Ltd. Recent Development Table 89. RemedyRepack，Inc. Company Information Table 90. RemedyRepack，Inc. Business Overview Table 91. RemedyRepack，Inc. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. RemedyRepack，Inc. Lurasidone Product Portfolio Table 93. RemedyRepack，Inc. Recent Development Table 94. Incepta Pharmaceuticals Ltd. Company Information Table 95. Incepta Pharmaceuticals Ltd. Business Overview Table 96. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio Table 98. Incepta Pharmaceuticals Ltd. Recent Development Table 99. Healthcare Pharmaceuticals Limited Company Information Table 100. Healthcare Pharmaceuticals Limited Business Overview Table 101. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio Table 103. Healthcare Pharmaceuticals Limited Recent Development Table 104. Bushu Pharmaceutical, LTD. Company Information Table 105. Bushu Pharmaceutical, LTD. Business Overview Table 106. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio Table 108. Bushu Pharmaceutical, LTD. Recent Development Table 109. Angelini Holding S.p.A. Company Information Table 110. Angelini Holding S.p.A. Business Overview Table 111. Angelini Holding S.p.A. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Angelini Holding S.p.A. Lurasidone Product Portfolio Table 113. Angelini Holding S.p.A. Recent Development Table 114. North America Lurasidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. North America Lurasidone Sales by Country (2021-2026) & (K Units) Table 116. North America Lurasidone Sales Market Share by Country (2021-2026) Table 117. North America Lurasidone Sales Forecast by Country (2027-2032) & (K Units) Table 118. North America Lurasidone Sales Market Share Forecast by Country (2027-2032) Table 119. North America Lurasidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Lurasidone Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Lurasidone Market Share by Country (2021-2026) Table 122. North America Lurasidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Lurasidone Market Share Forecast by Country (2027-2032) Table 124. Europe Lurasidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Europe Lurasidone Sales by Country (2021-2026) & (K Units) Table 126. Europe Lurasidone Sales Market Share by Country (2021-2026) Table 127. Europe Lurasidone Sales Forecast by Country (2027-2032) & (K Units) Table 128. Europe Lurasidone Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Lurasidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Lurasidone Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Lurasidone Market Share by Country (2021-2026) Table 132. Europe Lurasidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Lurasidone Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Lurasidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Lurasidone Sales by Country (2021-2026) & (K Units) Table 136. Asia-Pacific Lurasidone Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Lurasidone Sales Forecast by Country (2027-2032) & (K Units) Table 138. Asia-Pacific Lurasidone Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Lurasidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Lurasidone Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Lurasidone Market Share by Country (2021-2026) Table 142. Asia-Pacific Lurasidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Lurasidone Market Share Forecast by Country (2027-2032) Table 144. Latin America Lurasidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Latin America Lurasidone Sales by Country (2021-2026) & (K Units) Table 146. Latin America Lurasidone Sales Market Share by Country (2021-2026) Table 147. Latin America Lurasidone Sales Forecast by Country (2027-2032) & (K Units) Table 148. Latin America Lurasidone Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Lurasidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Lurasidone Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Lurasidone Market Share by Country (2021-2026) Table 152. Latin America Lurasidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Lurasidone Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Lurasidone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Lurasidone Sales by Country (2021-2026) & (K Units) Table 156. Middle East and Africa Lurasidone Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Lurasidone Sales Forecast by Country (2027-2032) & (K Units) Table 158. Middle East and Africa Lurasidone Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Lurasidone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Lurasidone Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Lurasidone Market Share by Country (2021-2026) Table 162. Middle East and Africa Lurasidone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Lurasidone Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Lurasidone Distributors List Table 167. Lurasidone Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Lurasidone Image Figure 2. Global Lurasidone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lurasidone Market Size (2021-2032) & (US$ Million) Figure 4. Global Lurasidone Sales (2021-2032) & (K Units) Figure 5. 120mg/tablet Image Figure 6. Global 120mg/tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20mg/tablet Image Figure 8. Global 20mg/tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 40mg/tablet Image Figure 10. Global 40mg/tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. 60mg/tablet Image Figure 12. Global 60mg/tablet Sales YoY Growth (2021-2032) & (K Units) Figure 13. 80mg/tablet Image Figure 14. Global 80mg/tablet Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Lurasidone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Lurasidone Market Share by Type 2025 VS 2032 Figure 17. North America Lurasidone Sales Market Share in Volume by Type in 2025 Figure 18. North America Lurasidone Sales Market Share in Value by Type in 2025 Figure 19. Europe Lurasidone Sales Market Share in Volume by Type in 2025 Figure 20. Europe Lurasidone Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Lurasidone Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Lurasidone Sales Market Share in Value by Type in 2025 Figure 23. Latin America Lurasidone Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Lurasidone Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Lurasidone Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Lurasidone Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Lurasidone Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Psychological Clinic Image Figure 32. Global Psychological Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Lurasidone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Lurasidone Market Share by Application 2025 VS 2032 Figure 37. North America Lurasidone Sales Market Share in Volume by Application in 2025 Figure 38. North America Lurasidone Sales Market Share in Value by Application in 2025 Figure 39. Europe Lurasidone Sales Market Share in Volume by Application in 2025 Figure 40. Europe Lurasidone Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Lurasidone Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Lurasidone Sales Market Share in Value by Application in 2025 Figure 43. Latin America Lurasidone Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Lurasidone Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Lurasidone Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Lurasidone Sales Market Share in Value by Application in 2025 Figure 47. North America Lurasidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Lurasidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Lurasidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Lurasidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Lurasidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Lurasidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Lurasidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Lurasidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Lurasidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Lurasidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Lurasidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Lurasidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Lurasidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Lurasidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Lurasidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Lurasidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Lurasidone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Lurasidone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Lurasidone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Lurasidone Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Lurasidone Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Lurasidone Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg/tablet
  • 20mg/tablet
  • 40mg/tablet
  • 60mg/tablet
  • 80mg/tablet
Applications
  • Hospital
  • Psychological Clinic
  • Others
Companies covered
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Square Pharmaceuticals Ltd.
  • RemedyRepack，Inc.
  • Incepta Pharmaceuticals Ltd.
  • Healthcare Pharmaceuticals Limited
  • Bushu Pharmaceutical, LTD.
  • Angelini Holding S.p.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lurasidone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lurasidone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lurasidone Market by Type
  6. 1.3.1 120mg/tablet
  7. 1.3.2 20mg/tablet
  8. 1.3.3 40mg/tablet
  9. 1.3.4 60mg/tablet
  10. 1.3.5 80mg/tablet
  11. 1.4 Global Lurasidone Market Size by Type
  12. 1.4.1 Global Lurasidone Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Lurasidone Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Lurasidone Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Lurasidone Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Lurasidone Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Lurasidone Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Lurasidone Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Lurasidone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lurasidone Industry Trends
  2. 2.2 Lurasidone Industry Drivers
  3. 2.3 Lurasidone Industry Opportunities and Challenges
  4. 2.4 Lurasidone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lurasidone Revenue (2021-2026)
  2. 3.2 Global Top Players by Lurasidone Sales (2021-2026)
  3. 3.3 Global Top Players by Lurasidone Price (2021-2026)
  4. 3.4 Global Lurasidone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lurasidone Major Company Production Sites & Headquarters
  6. 3.6 Global Lurasidone Company, Product Type & Application
  7. 3.7 Global Lurasidone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lurasidone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lurasidone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lurasidone Tier 1, Tier 2, and Tier 3
4 Lurasidone Regional Status and Outlook
  1. 4.1 Global Lurasidone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lurasidone Historic Market Size by Region
  3. 4.2.1 Global Lurasidone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lurasidone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lurasidone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lurasidone Forecasted Market Size by Region
  7. 4.3.1 Global Lurasidone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lurasidone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lurasidone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lurasidone by Application
  1. 5.1 Lurasidone Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Psychological Clinic
  4. 5.1.3 Others
  5. 5.2 Global Lurasidone Market Size by Application
  6. 5.2.1 Global Lurasidone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lurasidone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lurasidone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lurasidone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lurasidone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lurasidone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lurasidone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lurasidone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
  2. 6.1.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
  6. 6.1.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Sumitomo Dainippon Pharma Co., Ltd.
  8. 6.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
  9. 6.2.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
  10. 6.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
  12. 6.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
  13. 6.3 Square Pharmaceuticals Ltd.
  14. 6.3.1 Square Pharmaceuticals Ltd. Company Information
  15. 6.3.2 Square Pharmaceuticals Ltd. Business Overview
  16. 6.3.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
  18. 6.3.5 Square Pharmaceuticals Ltd. Recent Developments
  19. 6.4 RemedyRepack，Inc.
  20. 6.4.1 RemedyRepack，Inc. Company Information
  21. 6.4.2 RemedyRepack，Inc. Business Overview
  22. 6.4.3 RemedyRepack，Inc. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 RemedyRepack，Inc. Lurasidone Product Portfolio
  24. 6.4.5 RemedyRepack，Inc. Recent Developments
  25. 6.5 Incepta Pharmaceuticals Ltd.
  26. 6.5.1 Incepta Pharmaceuticals Ltd. Company Information
  27. 6.5.2 Incepta Pharmaceuticals Ltd. Business Overview
  28. 6.5.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
  30. 6.5.5 Incepta Pharmaceuticals Ltd. Recent Developments
  31. 6.6 Healthcare Pharmaceuticals Limited
  32. 6.6.1 Healthcare Pharmaceuticals Limited Company Information
  33. 6.6.2 Healthcare Pharmaceuticals Limited Business Overview
  34. 6.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
  36. 6.6.5 Healthcare Pharmaceuticals Limited Recent Developments
  37. 6.7 Bushu Pharmaceutical, LTD.
  38. 6.7.1 Bushu Pharmaceutical, LTD. Company Information
  39. 6.7.2 Bushu Pharmaceutical, LTD. Business Overview
  40. 6.7.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
  42. 6.7.5 Bushu Pharmaceutical, LTD. Recent Developments
  43. 6.8 Angelini Holding S.p.A.
  44. 6.8.1 Angelini Holding S.p.A. Company Information
  45. 6.8.2 Angelini Holding S.p.A. Business Overview
  46. 6.8.3 Angelini Holding S.p.A. Lurasidone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
  48. 6.8.5 Angelini Holding S.p.A. Recent Developments
7 North America by Country
  1. 7.1 North America Lurasidone Sales by Country
  2. 7.1.1 North America Lurasidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lurasidone Sales by Country (2021-2026)
  4. 7.1.3 North America Lurasidone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lurasidone Market Size by Country
  6. 7.2.1 North America Lurasidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lurasidone Market Size by Country (2021-2026)
  8. 7.2.3 North America Lurasidone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lurasidone Sales by Country
  2. 8.1.1 Europe Lurasidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lurasidone Sales by Country (2021-2026)
  4. 8.1.3 Europe Lurasidone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lurasidone Market Size by Country
  6. 8.2.1 Europe Lurasidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lurasidone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lurasidone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lurasidone Sales by Country
  2. 9.1.1 Asia-Pacific Lurasidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lurasidone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lurasidone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lurasidone Market Size by Country
  6. 9.2.1 Asia-Pacific Lurasidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lurasidone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lurasidone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lurasidone Sales by Country
  2. 10.1.1 South America Lurasidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lurasidone Sales by Country (2021-2026)
  4. 10.1.3 South America Lurasidone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lurasidone Market Size by Country
  6. 10.2.1 South America Lurasidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lurasidone Market Size by Country (2021-2026)
  8. 10.2.3 South America Lurasidone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lurasidone Sales by Country
  2. 11.1.1 Middle East and Africa Lurasidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lurasidone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lurasidone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lurasidone Market Size by Country
  6. 11.2.1 Middle East and Africa Lurasidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lurasidone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lurasidone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lurasidone Value Chain Analysis
  2. 12.1.1 Lurasidone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lurasidone Production Mode & Process
  7. 12.2 Lurasidone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lurasidone Distributors
  10. 12.2.3 Lurasidone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst